492029 Sigma-AldrichNRG1-β1/HRG1-β1 EGF Domain, Human, Recombinant
Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
Purity |
---|
≥97% by SDS-PAGE |
Product Information | |
---|---|
Form | Lyophilized |
Formulation | Lyophilized from 0.2 µm filtered acetonitrile, TFA, BSA. |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Biological activity | ED₅₀ = 0.06-0.3 ng/ml as measured in a serum-free proliferation assay using MCF-7 human breast adenocarcinoma cells. |
Purity | ≥97% by SDS-PAGE |
Physicochemical Information | |
---|---|
Contaminants | Endotoxin: ≤1.0 EU/µg protein |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
492029 | 0 |
Documentation
NRG1-β1/HRG1-β1 EGF Domain, Human, Recombinant Ficha datos de seguridad (MSDS)
Título |
---|
NRG1-β1/HRG1-β1 EGF Domain, Human, Recombinant Certificados de análisis
Cargo | Número de lote |
---|---|
492029 |
Referencias bibliográficas
Visión general referencias |
---|
Buonanno, A., and Fischbach, G.D. 2001. Curr. Opin. Neurobiol. 11, 287. Adlkofer, K. and Lai, C. 2000. Glia 29, 104. Garratt, A.N. et al. 2000. BioEssays 22, 987. Karey, K.P., et al. 1988. Cancer Res. 48, 4083. |